Article PDF
References
Walton RJ, Sherif JT, Noy GA, Alberti KGMM (1979) Improved metabolic profiles in insulin-treated diabetic patients given an alpha-glucoside hydrolase inhibitor. Br Med J 1:220–221
Laube H, Fouladfar M, Aubell R, Schmitz H (1980) Zur Wirkung des Glukosidasehemmers Bay g 5421 (Acarbose) auf das Blutzuckerverhalten bei adipösen Erwachsenendiabetikern. Arzneim Forsch 30: 1154–1157
Sachse G, Willms B (1979) Effect of the alpha-glucosidase inhibitor Bay g 5421 on blood glucose control of sulphonylureatreated diabetics and insulin-treated diabetics. Diabetologia 17: 287–290
Vierhapper H, Bratusch-Marrain P, Waldhäusl W (1978) Alphaglucoside hydrolase inhibition in diabetes. Lancet 2: 1386
Vierhapper H, Bratusch-Marrain P, Waldhäusl W (1981) Long term treatment of sulphonylurea-treated diabetics with the alpha-glucosidase inhibitor Bay g 5421 (Acarbose) Diabetologia 20: 586 (Letter)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sachse, G. Effect of a long-term acarbose therapy on the metabolic control of sulphonylurea-treated diabetic patients. Diabetologia 22, 221 (1982). https://doi.org/10.1007/BF00283759
Issue Date:
DOI: https://doi.org/10.1007/BF00283759